The immunosuppressive tumor microenvironment in hepatocellular carcinoma

Cancer Immunology, Immunotherapy

Volumn 58, Issue 6, 2009, Pages 877-886

  Pang, Yan Li ^a   Zhang, Hua Gang ^a   Peng, Ji Run ^a   Pang, Xue Wen ^a   Yu, Shu ^a   Xing, Qiao ^a   Yu, Xin ^a   Gong, Lei ^a   Yin, Yan Hui ^a   Zhang, Yu ^a   Chen, Wei Feng ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

Foxp3+ cells; Hepatocellular carcinoma; Immunosuppressive factors; Tumor infiltrating lymphocytes; Tumor microenvironment

Indexed keywords

CD56 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10; PERFORIN; TRANSCRIPTION FACTOR FOXP3;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CD3+ T LYMPHOCYTE; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL COUNT; CELL ISOLATION; CELL PROLIFERATION; CELL SUBPOPULATION; CLINICAL ARTICLE; CYTOKINE PRODUCTION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE STATUS; LIVER CELL CARCINOMA; MALE; MICROENVIRONMENT; PRIORITY JOURNAL; TUMOR ASSOCIATED LEUKOCYTE; TUMOR IMMUNITY; TUMOR LOCALIZATION;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD3; ANTIGENS, CD4; CARCINOMA, HEPATOCELLULAR; CELL PROLIFERATION; FEMALE; FLOW CYTOMETRY; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTERFERON-GAMMA; INTERLEUKIN-10; LYMPHOCYTE ACTIVATION; LYMPHOCYTES, TUMOR-INFILTRATING; MALE; MIDDLE AGED; T-LYMPHOCYTES; T-LYMPHOCYTES, REGULATORY;

EID: 63949086950     PISSN: 03407004     EISSN: 14320851     Source Type: Journal    
DOI: 10.1007/s00262-008-0603-5     Document Type: Article

References (52)

1. M Abou-Shady HU Baer H Friess P Berberat A Zimmermann H Graber LI Gold M Korc MW Buchler 1999 Transforming growth factor betas and their signaling receptors in human hepatocellular carcinoma Am J Surg 177 209 215
2. B Barnett I Kryczek P Cheng W Zou TJ Curiel 2005 Regulatory T cells in ovarian cancer: biology and therapeutic potential Am J Reprod Immunol 54 369 377
3. P Bedossa E Peltier B Terris D Franco T Poynard 1995 Transforming growth factor-beta 1 (TGF-beta 1) and TGF-beta 1 receptors in normal, cirrhotic, and neoplastic human livers Hepatology 21 760 766
4. M Beyer JL Schultze 2006 Regulatory T cells in cancer Blood 108 804 811
5. +T cell responses in patients with hepatocellular carcinoma J Immunol 174 1709 1716
6. S Chattopadhyay NG Chakraborty B Mukherji 2005 Regulatory T cells and tumor immunity Cancer Immunol Immunother 54 1153 1161
7. + regulatory T cells by TGF-beta induction of transcription factor Foxp3 J Exp Med 198 1875 1886
8. H Conroy NA Marshall KH Mills 2008 TLR ligand suppression or enhancement of Treg cells? A double-edged sword in immunity to tumours Oncogene 27 168 180
9. TJ Curiel G Coukos L Zou X Alvarez P Cheng P Mottram M Evdemon-Hogan JR Conejo-Garcia L Zhang M Burow Y Zhu S Wei I Kryczek B Daniel A Gordon L Myers A Lackner ML Disis KL Knutson L Chen W Zou 2004 Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival Nat Med 10 942 949
10. J Dannull Z Su D Rizzieri BK Yang D Coleman D Yancey A Zhang P Dahm N Chao E Gilboa J Vieweg 2005 Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells J Clin Invest 115 3623 3633
11. + natural T cells with distinct cytotoxic activities and Th1, Th2, and Th0 cytokine secretion patterns J Immunol 163 2314 2321
12. OJ Finn 2003 Cancer vaccines: between the idea and the reality Nat Rev Immunol 3 630 641
13. + regulatory T cells Nat Immunol 4 330 336
14. J Fu D Xu Z Liu M Shi P Zhao B Fu Z Zhang H Yang H Zhang C Zhou J Yao L Jin H Wang Y Yang YX Fu FS Wang 2007 Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients Gastroenterology 132 2328 2339
15. Q Gao SJ Qiu J Fan J Zhou XY Wang YS Xiao Y Xu YW Li ZY Tang 2007 Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection J Clin Oncol 25 2586 2593
16. E Gilboa 2004 The promise of cancer vaccines Nat Rev Cancer 4 401 411
17. TF Greten MP Manns F Korangy 2008 Immunotherapy of HCC Rev Recent Clin Trials 3 31 39
18. S Hori T Nomura S Sakaguchi 2003 Control of regulatory T cell development by the transcription factor Foxp3 Science 299 1057 1061
19. P Hwu RS Freedman 2002 The immunotherapy of patients with ovarian cancer J Immunother 25 189 201
20. + regulatory T cells J Immunol 177 896 904
21. A Kawata Y Une M Hosokawa J Uchino H Kobayashi 1992 Tumor-infiltrating lymphocytes and prognosis of hepatocellular carcinoma Jpn J Clin Oncol 22 256 263
22. + T regulatory cells Nat Immunol 4 337 342
23. HT Khong NP Restifo 2002 Natural selection of tumor variants in the generation of "tumor escape" phenotypes Nat Immunol 3 999 1005
24. + regulatory T cells affect the development and progression of hepatocarcinogenesis Clin Cancer Res 13 902 911
25. F Korangy LA Ormandy JS Bleck J Klempnauer L Wilkens MP Manns TF Greten 2004 Spontaneous tumor-specific humoral and cellular immune responses to NY-ESO-1 in hepatocellular carcinoma Clin Cancer Res 10 4332 4341
26. + regulatory T-cells in cancer Immunol Res 32 155 168
27. + T regulatory cells: role of tumor-derived TGF-beta J Immunol 178 2883 2892
28. Y Liu S Daley VN Evdokimova DD Zdobinski DM Potter LH Butterfield 2006 Hierarchy of alpha fetoprotein (AFP)-specific T cell responses in subjects with AFP-positive hepatocellular cancer J Immunol 177 712 721
29. JM Llovet A Burroughs J Bruix 2003 Hepatocellular carcinoma Lancet 362 1907 1917
30. +human regulatory T cells in vivo: kinetics of Treg depletion and alterations in immune functions in vivo and in vitro Int J Cancer 120 2723 2733
31. CJ Melief RE Toes JP Medema SH van der Burg F Ossendorp R Offringa 2000 Strategies for immunotherapy of cancer Adv Immunol 75 235 282
32. KH Mills 2004 Regulatory T cells: friend or foe in immunity to infection? Nat Rev Immunol 4 841 855
33. DW O'Neill S Adams N Bhardwaj 2004 Manipulating dendritic cell biology for the active immunotherapy of cancer Blood 104 2235 2246
34. + regulatory T cells in patients with gastrointestinal malignancies: possible involvement of regulatory T cells in disease progression Cancer 98 1089 1099
35. + regulatory T cells in the peripheral circulation of patients with head and neck cancer Br J Cancer 92 913 920
36. G Schuler B Schuler-Thurner RM Steinman 2003 The use of dendritic cells in cancer immunotherapy Curr Opin Immunol 15 138 147
37. + T-cell response to HLA-A2-restricted NY-ESO-1b peptide in hepatocellular carcinoma patients Clin Cancer Res 10 6946 6955
38. Y Shirai S Kawata S Tamura N Ito H Tsushima K Takaishi S Kiso Y Matsuzawa 1994 Plasma transforming growth factor-beta 1 in patients with hepatocellular carcinoma. Comparison with chronic liver diseases Cancer 73 2275 2279
39. E Unitt SM Rushbrook A Marshall S Davies P Gibbs LS Morris N Coleman GJ Alexander 2005 Compromised lymphocytes infiltrate hepatocellular carcinoma: the role of T-regulatory cells Hepatology 41 722 730
40. Y Wada O Nakashima R Kutami O Yamamoto M Kojiro 1998 Clinicopathological study on hepatocellular carcinoma with lymphocytic infiltration Hepatology 27 407 414
41. YY Wan RA Flavell 2005 Identifying Foxp3-expressing suppressor T cells with a bicistronic reporter Proc Natl Acad Sci USA 102 5126 5131
42. RF Wang 2006 Functional control of regulatory T cells and cancer immunotherapy Semin Cancer Biol 16 106 114
43. + regulatory T-cells in cancer Semin Cancer Biol 16 73 79
44. AM Wolf D Wolf M Steurer G Gastl E Gunsilius B Grubeck-Loebenstein 2003 Increase of regulatory T cells in the peripheral blood of cancer patients Clin Cancer Res 9 606 612
45. + regulatory T-cells is preserved in cancer patients Cancer Immunol Immunother 55 1198 1208
46. Q Xing XW Pang JR Peng YH Yin Y Li X Yu SP Zhou Y Zhang WF Chen 2008 Identification of new cytotoxic T-lymphocyte epitopes from cancer testis antigen HCA587 Biochem Biophys Res Commun 372 331 335
47. + regulatory T-cells in the liver of patients with hepatocellular carcinoma J Hepatol 45 254 262
48. C Yee P Greenberg 2002 Modulating T-cell immunity to tumours: new strategies for monitoring T-cell responses Nat Rev Cancer 2 409 419
49. + cells in patients with hepatocellular carcinoma J Hepatol 40 102 109
50. + T cell responses to HLA-A2 restricted MAGE-A3 p271-279 peptide in hepatocellular carcinoma patients without vaccination Cancer Immunol Immunother 56 1945 1954
51. L Zitvogel A Tesniere G Kroemer 2006 Cancer despite immunosurveillance: immunoselection and immunosubversion Nat Rev Immunol 6 715 727
52. W Zou 2005 Immunosuppressive networks in the tumour environment and their therapeutic relevance Nat Rev Cancer 5 263 274